The executive order, which Biden signed in October 2022, had not spurred any lower drug prices by the time Trump revoked it Jan. 20. The order directed the Health and Human Services Department ...
The order signaled that the president intends to promote an industry that faced scrutiny during the Biden administration — and that he has a personal stake in.